1. Home
  2. NAMS vs YY Comparison

NAMS vs YY Comparison

Compare NAMS & YY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • YY
  • Stock Information
  • Founded
  • NAMS 2019
  • YY 2005
  • Country
  • NAMS Netherlands
  • YY Singapore
  • Employees
  • NAMS N/A
  • YY N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • YY EDP Services
  • Sector
  • NAMS Health Care
  • YY Technology
  • Exchange
  • NAMS Nasdaq
  • YY Nasdaq
  • Market Cap
  • NAMS 2.7B
  • YY 2.2B
  • IPO Year
  • NAMS N/A
  • YY 2012
  • Fundamental
  • Price
  • NAMS $18.57
  • YY $48.97
  • Analyst Decision
  • NAMS Strong Buy
  • YY Hold
  • Analyst Count
  • NAMS 7
  • YY 3
  • Target Price
  • NAMS $41.33
  • YY $35.00
  • AVG Volume (30 Days)
  • NAMS 646.5K
  • YY 344.1K
  • Earning Date
  • NAMS 03-04-2025
  • YY 03-17-2025
  • Dividend Yield
  • NAMS N/A
  • YY 1.60%
  • EPS Growth
  • NAMS N/A
  • YY N/A
  • EPS
  • NAMS N/A
  • YY 3.11
  • Revenue
  • NAMS $33,594,000.00
  • YY $2,258,181,000.00
  • Revenue This Year
  • NAMS $131.53
  • YY $0.76
  • Revenue Next Year
  • NAMS N/A
  • YY $1.88
  • P/E Ratio
  • NAMS N/A
  • YY $15.73
  • Revenue Growth
  • NAMS 78.77
  • YY N/A
  • 52 Week Low
  • NAMS $15.19
  • YY $27.88
  • 52 Week High
  • NAMS $27.29
  • YY $51.82
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 29.65
  • YY 62.93
  • Support Level
  • NAMS $18.88
  • YY $46.64
  • Resistance Level
  • NAMS $20.46
  • YY $51.19
  • Average True Range (ATR)
  • NAMS 1.11
  • YY 1.93
  • MACD
  • NAMS -0.09
  • YY 0.26
  • Stochastic Oscillator
  • NAMS 5.84
  • YY 71.21

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About YY JOYY Inc.

JOYY Inc is a global technology company offering comprehensive innovation capabilities. The company enables users to interact with others in real time. The group is actively exploring and expanding its global commerce Software-as-a-Service and solutions business. JOYY emphasizes technological innovation and is recognized in the industry for its significant number of patent applications and licenses.

Share on Social Networks: